These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 6865968)
1. Methodological problems of using platelet MAO in psychiatric research. Demisch L; Kaczmarczyk P; Gebhart P Mod Probl Pharmacopsychiatry; 1983; 19():265-77. PubMed ID: 6865968 [No Abstract] [Full Text] [Related]
2. Platelet monoamine oxidase activity in children and adolescents with psychiatric disorders. Young JG; Cohen DJ; Waldo MC; Feiz R; Roth JA Schizophr Bull; 1980; 6(2):324-33. PubMed ID: 7375865 [TBL] [Abstract][Full Text] [Related]
3. Platelet monoamine oxidase as a function of nongenetic factors. Friedhoff AJ; Miller JC Schizophr Bull; 1980; 6(2):314-9. PubMed ID: 6103576 [TBL] [Abstract][Full Text] [Related]
6. Low platelet monoamine oxidase activity: a possible biochemical correlate of borderline schizophrenia. Baron M; Levitt M; Perlman R Psychiatry Res; 1980 Dec; 3(3):329-35. PubMed ID: 6936727 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of human platelets. VII. Platelet monoamine oxidase activity in normals and patients with autoimmune thrombocytopenic purpura and reactive thrombocytosis: its relationship to platelet protein density. Friedhoff AJ; Miller JC; Karpatkin S Blood; 1978 Feb; 51(2):317-23. PubMed ID: 563748 [No Abstract] [Full Text] [Related]
8. Platelet MAO activity and high risk for psychopathology in a German population. Propping P; Friedl W Mod Probl Pharmacopsychiatry; 1983; 19():304-14. PubMed ID: 6865970 [No Abstract] [Full Text] [Related]
9. Platelet monoamine oxidase in healthy subjects: the "biochemical high-risk paradigm" revisited. Propping P; Rey ER; Friedl W; Beckmann H Arch Psychiatr Nervenkr (1970); 1981; 230(3):209-19. PubMed ID: 7295010 [TBL] [Abstract][Full Text] [Related]
10. Catecholamine-thyroid hormone interactions: I. Thyroid hormone and platelet MAO activity in psychiatrically disturbed children. Young JG; Feiz R; Roth JA; Waldo MC; Cohen DJ Schizophr Bull; 1982; 8(2):297-300. PubMed ID: 7112043 [No Abstract] [Full Text] [Related]
11. Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients. Propping P; Friedl W Psychopharmacology (Berl); 1979 Nov; 65(3):265-72. PubMed ID: 117498 [TBL] [Abstract][Full Text] [Related]
12. Biological high-risk paradigm and platelet MAO activity in community samples. Buchsbaum MS; Coursey RD Mod Probl Pharmacopsychiatry; 1983; 19():278-86. PubMed ID: 6865969 [No Abstract] [Full Text] [Related]
13. Human platelet monoamine oxidase--a useful enzyme in the study of psychiatric disorders? Fowler CJ; Tipton KF; MacKay AV; Youdim MB Neuroscience; 1982 Jul; 7(7):1577-94. PubMed ID: 6956813 [No Abstract] [Full Text] [Related]
14. Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die? Fleissner A; Seifert R; Schneider K; Eckert W; Fuisting B Eur Arch Psychiatry Neurol Sci; 1987; 237(1):8-15. PubMed ID: 3480800 [TBL] [Abstract][Full Text] [Related]
16. Protein content and monoamine oxidase activity in platelets. Zeller EA; Davis JM Schizophr Bull; 1980; 6(2):267-74. PubMed ID: 7375859 [TBL] [Abstract][Full Text] [Related]
17. Platelet monoamine oxidase activity and behavioral response to pharmacotherapy in psychiatric patients. Rosen AJ; Wirtshafter D; Pandey GN; Davis JM Psychiatry Res; 1982 Feb; 6(1):49-59. PubMed ID: 6120529 [TBL] [Abstract][Full Text] [Related]
18. 2-year follow-up of subjects and their families defined as at risk for psychopathology on the basis of platelet MAO activities. 2-year follow-up of low platelet MAO. Coursey RD; Buchsbaum MS; Murphy DL Neuropsychobiology; 1982; 8(1):51-6. PubMed ID: 7073872 [TBL] [Abstract][Full Text] [Related]